#9: What is the USP 797 impact beyond pharmacy? | Jim Jorgenson | Visante Inc.
Join Jim Jorgenson, MS, RPh, FASHP, CEO, as he discusses the preparation for the release of the revised USP 797 and how this chapter will impact all locations that are compounding sterile products.
Learn more about Visante at visanteinc.com.
Learn more about RXinsider and our Thought Leader Video Series offering here: rxinsider.com.